Loading clinical trials...
Loading clinical trials...
Functional Neuroimaging Effects of the N-methyl-D-aspartate Receptor (NMDAR) Partial Agonist, GLYX-13, on Learning and Memory in Healthy Individuals
Conditions
Interventions
GLYX-13
Placebo
Locations
1
United States
Northwestern University
Chicago, Illinois, United States
Start Date
May 1, 2013
Primary Completion Date
January 1, 2016
Completion Date
January 1, 2016
Last Updated
April 20, 2023
NCT06290258
NCT07310264
NCT00090662
NCT06716502
NCT07483606
NCT06342713
Lead Sponsor
Northwestern University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions